Drug
PT150
PT150 is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
25%
Ph phase_1
3
75%
Phase Distribution
3
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 2Efficacy & side effects
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (75.0%)
Phase 21 (25.0%)
Trials by Status
not_yet_recruiting125%
completed250%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingphase_2
Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans
NCT07187011
recruitingphase_1
PT150 Drug for Use in Alcohol Use Disorder
NCT06712602
completedphase_1
Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study)
NCT04331288
completedphase_1
Clinical Trial to Evaluate the Safety of PT150 (Formerly ORG34517) When it is Taken Concurrently With Alcohol
NCT03548714
Clinical Trials (4)
Showing 4 of 4 trials
NCT07187011Phase 2
Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans
NCT06712602Phase 1
PT150 Drug for Use in Alcohol Use Disorder
NCT04331288Phase 1
Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study)
NCT03548714Phase 1
Clinical Trial to Evaluate the Safety of PT150 (Formerly ORG34517) When it is Taken Concurrently With Alcohol
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4